Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $95.34 USD
Change Today -0.26 / -0.27%
Volume 1.8M
NVS On Other Exchanges
New York
SIX Swiss Ex
SIX Swiss Ex
As of 2:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for novartis ag-sponsored adr (NVS)

Currency in
Millions of US Dollars
As of:Dec 31
Dec 31
Dec 31
Dec 31
4 Year
NET INCOME9,113.09,270.09,175.010,210.0
Depreciation & Amortization1,728.01,517.01,554.01,586.0
Amortization of Goodwill and Intangible Assets3,028.02,623.02,698.02,775.0
DEPRECIATION & AMORTIZATION, TOTAL4,756.04,140.04,252.04,361.0
(Gain) Loss from Sale of Asset-518.0-256.0-347.0-622.0
(Gain) Loss on Sale of Investment192.
Asset Writedown & Restructuring Costs1,032.0302.0153.0321.0
Other Operating Activities1,056.01,480.0997.02,483.0
(Income) Loss on Equity Investments-528.0-549.0-599.0-1,918.0
Net Cash from Discontinued Operations--384.0557.0-1.0
Change in Accounts Receivable-732.0215.0-548.0-367.0
Change in Inventories45.0-656.0-454.0-506.0
Change in Accounts Payable195.0523.0414.0142.0
Change in Other Working Capital-1,092.0-1,371.0-1,137.0-1,019.0
CASH FROM OPERATIONS14,309.014,194.013,174.013,897.0
Capital Expenditure-2,167.0-2,458.0-2,903.0-2,624.0
Sale of Property, Plant, and Equipment61.
Cash Acquisitions-591.0-1,741.0-42.0-331.0
Sale (Purchase) of Intangible Assets423.0-197.0-379.0-534.0
Investments in Marketable & Equity Securities1,503.0-1,069.080.03,479.0
CASH FROM INVESTING-792.0-5,675.0-3,352.0881.0
Short-Term Debt Issued----596.0--
Long-Term Debt Issued281.01,979.093.06,024.0
TOTAL DEBT ISSUED281.01,979.0689.06,024.0
Short Term Debt Repaid-3,054.0-1,737.0---107.0
Long Term Debt Repaid-28.0-704.0-2,022.0-2,599.0
TOTAL DEBT REPAID-3,082.0-2,441.0-2,022.0-2,706.0
Issuance of Common Stock159.0414.01,693.02,400.0
Repurchase of Common Stock-3,628.0-505.0-2,930.0-6,915.0
Common Dividends Paid-5,368.0-6,030.0-6,100.0-6,810.0
TOTAL DIVIDEND PAID-5,368.0-6,030.0-6,100.0-6,810.0
Other Financing Activities-3,386.0-92.0-99.0-140.0
CASH FROM FINANCING-15,024.0-6,675.0-8,769.0-8,147.0
Foreign Exchange Rate Adjustments-103.0-1.082.0-295.0
NET CHANGE IN CASH-1,610.01,843.01,135.06,336.0

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVS:US $95.34 USD -0.26

NVS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Gilead Sciences Inc $101.97 USD -2.30
Johnson & Johnson $92.65 USD -0.70
Merck & Co Inc $52.84 USD -0.14
Nestle SA SFr.71.10 CHF +0.80
Sanofi €89.51 EUR +2.27
View Industry Companies

Industry Analysis


Industry Average

Valuation NVS Industry Range
Price/Earnings 24.2x
Price/Sales 4.5x
Price/Book 2.9x
Price/Cash Flow 13.1x
TEV/Sales 4.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-SPONSORED ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at